- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
A GP challenged a Prescriber journal ad for Micardis/Micardis Plus. The Panel found the headline implied long-term cardiovascular benefit inconsistent with the…
Novo Nordisk-funded Times supplement included interview claims about liraglutide trial benefits before approval. Panel found public promotion, lack of due diligence and…
A pharmacist alleged a Crestor journal ad implied NICE cholesterol targets had been reduced and omitted first-line NICE advice. The Panel found…
Bayer Schering was found to have promoted Xarelto (rivaroxaban) before UK marketing authorisation via a UK exhibition stand and a journal insert,…
A member of the public saw Triumeq promotional material on a train on a third-party employee’s iPad. Panel found no promotion to…
GSK admitted a travel health pricing proposal sent to buying groups became promotional due to “Excellent Products”. It lacked PI, INNs and…
An internal email implied AUA meeting sponsorship was tied to protecting/growing Zoladex prescriptions. One rep forwarded it to a doctor. PMCPA ruled…
A hospital doctor alleged a Lundbeck rep made a joint visit with a competitor rep and discussed rival products. The complainant was…
A rheumatoid arthritis supplement funded by Roche/Chugai was stapled into the Health Service Journal. On appeal, the PMCPA ruled the inside pages…
Anonymous key account manager alleged verbal contact-rate targets forced Code breaches. Panel found no evidence targets required excessive calls; company data suggested…
AstraZeneca’s UK journal ad for Seroquel claimed a ‘favourable weight profile across the full dose range’. PMCPA ruled the claim misleading/unsubstantiated and…
Astellas alleged Genus’ Eczmol ad copied Locoid’s animal imagery and “strong/gentle” strapline, risking confusion. The Panel found similarities but different execution and…
Anonymous complaint alleged sales reps used an “Oncology Product Pipeline Update” to promote unlicensed products. Panel found reps weren’t instructed to promote…
Astellas voluntarily admitted using incomplete prescribing information across multiple medicines and materials over several years, including omissions of serious/common adverse reactions and…
Novartis retweeted an HCP’s positive tweet about a Novartis haematology meeting. Complaint alleged disguised promotion, public promotion and breach of a prior…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.